Get a free quote now.
Deciding Between Vancomycin AUC Monitoring Approaches
In a previous post, we covered why the new consensus guidelines on therapeutic monitoring of vancomycin have the potential to improve patient safety by reducing rates of acute kidney injury (AKI). We’ve also reviewed the clinical and technical considerations of the 2-level approach using first-order pharmacokinetic (PK) equations and Bayesian-derived approaches to vancomycin AUC-monitoring.
If your hospital or health system is committed to adopting AUC monitoring to guide vancomycin dosing as recommended by the new consensus guidelines, you’re likely trying to decide between these two approaches. To help you make an informed decision, we’ve summarized the tradeoffs in this infographic.